Scout | FDA ORISE Fellowship — Clinical Pharmacology & MIDD for Nucleotide Therapeutics (Neurology)

This opportunity is no longer accepting applications.

grant

FDA ORISE Fellowship — Clinical Pharmacology & MIDD for Nucleotide Therapeutics (Neurology)

A full-time ORISE fellowship at FDA CDER (White Oak, MD) to conduct regulatory-science research on dose selection and optimization for nucleotide-based neurologic therapies (antisense oligos, siRNA, mRNA) using model-informed drug development (MIDD). Fellows will review FDA regulatory documents, extract and synthesize evidence on safety margins, nonclinical data, biomarkers and PK/PD to produc…

Source

Agency: U.S. Food and Drug Administration

Dates

Application Deadline: May 31, 2026

Eligibility

industry:education

industry:energy

industry:research

location:maryland

Keywords

clinical pharmacology

model-informed drug development

nucleotide therapeutics

dose optimization

neurology

regulatory science

fda fellowship

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers